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Background: The impact of the comorbidity between Obsessive-Compulsive Disorder
(OCD) and Bipolar Disorder Spectrum (BDS) remains to be clarified. The objective of this
study was to examine the lifetime prevalence of OCD, the strength of the association of
OCD with comorbid BDS and the role of comorbidity of OCD with BDS in the impairment
of health-related quality of life (HRQoL) in an Italian community survey.
Methods: The study is a community survey. The sample (N = 2,267; women: 55.3%)
was randomly selected after stratification by sex and four age groups from the municipal
records of the adult population of one urban, one suburban, and at least one rural area
in six Italian regions. Physicians using a semi-structured interview (Advanced Tools and
Neuropsychiatric Assessment Schedule, ANTAS-SCID) made Diagnostic and Statistical
Manual of Mental Disorders – 4th revision (DSM-IV) diagnoses of OCD, Major Depressive
Disorder (MDD) and Bipolar Disorder (BD). HR-QoL was measured by the Health Survey
Short Form (SF-12). Lifetime Hypomania and subthreshold hypomania were screened
by the Mood Disorder Questionnaire (MDQ). BDS was defined as the sum of people
shown to be positive for hypomania by the MDQ—with or without a mood disorder
diagnosis—plus people with a BD-DSMIV diagnosis even if negative for hypomania at
the MDQ.
Results: Overall, 44 subjects were diagnosed with OCD, 6 with MDD and 1 with BD.
The lifetime prevalence of OCD was 1.8% in men (n = 18) and 2.0% in women (n =
26). MDD with lifetime subthreshold hypomania (i.e., people screened positive at the
MDQ, even without diagnosed mania or hypomania at the interview) was associated with
OCD (OR = 18.15, CI 95% 2.45–103.67); MDD without subthreshold hypomania (and
screened negative at theMDQ) was not (OR= 2.33, CI 95% 0.69–7.01). People with BDS
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were strongly associated with OCD (OR = 10.5, CI 95% 4.90–12.16,). People with OCD
and BDS showed significantly poorer HR-QoL than people with OCD without BDS (F =
9.492; P < 0.003).
Discussion: The study found a strong association between BDS and OCD. BDS
comorbid with OCD was associated with more severe impairment of HR-QoL than OCD
without comorbid BDS. Identification of symptoms of hypomania, including subthreshold
symptoms,may therefore be important in people with OCD as theymight predict a course
with poorer HR-QoL.
Keywords: obsessive compulsive disorders, bipolar disorder, epidemiology, community survey, bipolar spectrum,
quality of life
INTRODUCTION
Obsessive-Compulsive Disorder (OCD) is a common, disabling
neuropsychiatric disorder known to be highly comorbid with
mood, anxiety, and other disorders classified in the “Obsessive-
Compulsive And Related Disorders” group (1, 2). Comorbidity
with other psychiatric disorders increases the levels of distress
and disability, while the association with Bipolar Disorder (BD)
is thought to be particularly harmful and difficult to treat (2).
Although there is a considerable body of recent research
on OCD, most studies have focused on course, treatment,
pathogenesis, and brain imaging, while methodological
differences between published epidemiological studies leave
many aspects of prevalence, and especially the comorbidity of
OCD with mood disorders, in need of clarification (3, 4).
The estimated prevalence of OCD varies across surveys (2),
perhaps as a consequence of different approaches in their design
and methodology and of the diagnostic method adopted (1, 3, 5).
However, the vast majority of studies, including the more recent
ones adopting more structured interviews and lay interviewers
(3–7) have found lifetime prevalence rates in a range of 2–3%.
However, all of these results are far below the OCD findings
from the recent WHO Health Survey, which reported a lifetime
prevalence of DSM-IV OCD of 6.2%, ranging from 5.8% in
low- and middle-income countries to 6.9% in high-income
countries (8).
Lifetime OCD occurring in people with lifetime diagnosis of
BD range from 11 to 21% in population-based surveys (9, 10).
Lower values were found in hospital-based studies, ranging from
3 to 16% (11, 12). It is not known whether this could be due to
the lower diagnostic threshold (of one or both of the disorders)
in the community surveys combined with higher co-morbidity
in sub-threshold cases, or if it is due to higher accuracy of the
diagnoses with co-morbidity produced by the use of standardized
tools in community surveys. Conversely, there is a wide variance
in the reported lifetime prevalence of Bipolar Disorder Spectrum
(BDS) in people with OCD, ranging from 6 to 55% depending
on the method of investigation and the definition of the bipolar
spectrum adopted (12). A recent meta-analysis estimated the
lifetime prevalence of OCD in patients with BD to be 10.9%
(95% CI: 7.8–14.4%) (13). This estimated lifetime prevalence was
several times higher than the prevalence of OCD estimated in the
general population (2.5%; 1.9–3.1%) (13).
There are authors who include in their definitions of
the bipolar spectrum those patients in which episodes of
subthresholdmania occur concomitantly with lifetime depressive
episodes, anxiety disorders, obsessive compulsive disorders, and
substance abuse disorder but without previous episodes of mania
or hypomania (14). However, according to some authors the
spectrum also includes the hyperthymic temperament, even
without episodes of impaired mood (15). Yet some other authors
define the bipolar spectrum as including those symptoms that
have been seen to be associated with or to precede the onset of
bipolar disorder: sleep disturbances, subthreshold anxiety and
depression, behavioral dyscontrol, and irritability (16).
People with both OCD and BD have been found to
show greater disability, poorer HR-QoL, and poorer treatment
response compared to those with only one of the two disorders
(12). However, a similarly negative outcome was also found in
patients having OCD in association with conditions of the BDS,
i.e., with subthreshold hypomania but without a DSM diagnosis
of BD (12).
It should further be noted that in epidemiological studies the
approach based on lay interviewers and structured interviews
has been of little help in explaining the role of BD, since this
method of information gathering hinders the identification of
the disorder, particularly BD II (alternating episodes of Major
Depressive Disorder [MDD] and of hypomania). The frequent
lack of subjective insight regarding episodes of hypomania means
that a correct diagnosis requires sources other than self-reporting
(i.e., how these patients appear to others, and what relatives
and friends say about the patient) (14). Such information is
systematically gathered in clinical practice but is not collected
by structured interviews conducted by lay interviewers in
epidemiological surveys. This approach has led to the frequent
mis-identification of episodes of the depressive phase of the BD
as a part of a MDD (14).
This issue is particularly relevant for the study of the
comorbidity of OCD with mood disorders. Data from the Zurich
study (17) have underlined a closer association between OCD
and BD (but also with the subthreshold bipolar syndromes)
than between OCD and MDD. The Zurich study was the
only epidemiological survey repeated over time (which is an
additional source for identifying lifetime mania) and also the
only one, in recent years, in which clinicians made the diagnoses.
That study further indicated that comorbidity with BD (and
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with subthreshold bipolar syndromes) is a powerful factor in
determining impairment in people suffering from OCD (2).
The objectives of this paper are therefore to extend the
investigation of the association between OCD and bipolar
spectrum by (a) identifying the lifetime prevalence of OCD in
a community study in six Italian regions, using semi-structured
interviews conducted by physicians with experience in mental
health; (b) determining the comorbidity of OCD with mood
disorders, both MDD and BD, including subthreshold manic
episodes (BDS broadly defined); and (c) clarifying how far OCD
in association with MDD, BD, and subthreshold manic episodes
impairs HR-QoL.
METHODS
Design: Community Survey
Sample and Setting
The sample was randomly drawn from the municipal records of
one urban, one suburban, and at least one rural area in six Italian
regions, which were chosen because they are representative, in
terms of geography and socio-cultural characteristics, of the
entire national territory. Randomization for those registers was
performed after stratification by sex and four age groups (18–24;
25–44; 45–64; >64). Participants were contacted by phone and
mail. The interviews were carried out by physicians, face to face
in the subjects’ homes. The survey methodology was published
earlier (18). The main objective of that study was to measure the
relationship between the use of drugs and psychiatric disorders
in the community.
Tools
1) The Advanced Tools and Neuropsychiatric Assessment
Schedule -Structured Clinical Interview for DSM-IV
(ANTAS—SCID-IV) (18), a semi-structured, clinician
administered, computerized interview derived from the
SCID (19); ANTAS–SCID-IV allows diagnosis of Mood,
Anxiety and Eating disorders according to DSM—IV-TR (20)
high reliable with SCID (18).
2) The Italian version (21) of the Mood Disorder Questionnaire
(MDQ) (22) was adopted to assess lifetime hypomanic
symptoms and subthreshold hypomanic episodes. Although
this tool shows low accuracy as a screener for DSM—defined
BD (23), the research has shown that it is acceptable for
identifying subthreshold cases (15).
3) The cut-off score for screening positive for BDS was
established on the basis of the standardization study (21)
and involved scoring “Yes” to ≥8 items on a list of the 13
best known symptoms of mania / hypomania and “yes” to
a question “have several of these ever happened during the
same period of time?”
4) The Health Survey Short Form (SF−12) (24) was used to
assess perceived HR-QoL as a measure of the impact of OCD
and its comorbid conditions. The SF-12 covers physical
functioning, physical health, emotional state, physical
pain, general health, vitality, social activity, and mental
health. The HR-QoL is considered a relevant construct
for measuring outcome in chronic diseases that require
long-term treatments and greatly impair and impact daily
life (25).
Definitions and Subgroups
OCD, MDD, and BD were defined according to DSM-IV criteria.
The BDS group was defined as including either all those
with DSM-IV BD (i.e., diagnosed with Bipolar Disorder on the
ANTAS-SCID) and all those screening positive on theMDQ. This
group thus includes those diagnosed (on the ANTAS-SCID) with
BD or with MDD and lifetime hypomanic symptoms (i.e., MDQ
positives), and those with lifetime subthreshold hypomania
(i.e., MDQ positives) but having no diagnosis of MDD or BD
according ANTAS-SCID.
The MDD group was thus sub-divided into those with
and without subthreshold lifetime hypomania (i.e., respectively,
screening positive or negative on the MDQ) and included in or
excluded from the BDS group.
Statistical Analysis
The odds ratio (univariate analysis) for DSM-IV OCD diagnosis
and age, gender, and comorbidity with DSM-IV MDD, DSM-
IV BD, and BDS (i.e., any case diagnosed with BD according to
DSM-IV or screened positive on the MDQ) was calculated using
one of the groups in each table as a “pivot.” Statistical significance
was calculated using the χ2 test. Odds, ratios and 95% confidence
intervals were calculated using Miettinen’s simplified method
(26). The comparisons between the scores on the SF-12 in the
different groups were calculated by one-way ANOVA.
The burden in the worsening of HR-QoL attributable to OCD
was calculated as the difference between the HR-QoL (mean
score on the SF-12) in a sample from the same community
survey database of people without OCD and the SF-12 mean
score of thosewithOCD. The randomization was conducted after
standardization by blocks. For each personwithOCD two people,
matched by age and sex, were selected by randomization from the
cell of all without OCD.
A similar method was adopted for measuring the burden
in the deterioration of HR-QoL attributable to OCD with
BDS. Thus, the attributable burden of OCD with BDS was the
difference between the HR-QoL (mean score on the SF-12) in a
sample from the community survey database of people without
OCD and the SF-12 mean score of those with OCD plus BDS
as above defined (BD + all positives on MDQ). The proportion
of the sample drawn for comparison (without OCD) was 2/1 for
OCD without BDS and 4/1 for OCD with BDS.
RESULTS
Overall, 44 subjects were diagnosed with OCD at the ANTAS-
SCID, 6 were diagnosed with MDD and just 1 was diagnosed
with BD.
Table 1 illustrates the lifetime prevalence for OCD by age
and gender in the epidemiological sample (2,267 subjects, 1,253
women [55.3%]). The prevalence of OCD was 1.8% in men (n =
18) and 2.0% in women (n = 26); with no difference by gender
(OR = 1.15, CI 95% 0.61–2.19). The prevalence rate among
Frontiers in Psychiatry | www.frontiersin.org 3 March 2020 | Volume 11 | Article 188
Carta et al. Bipolar Spectrum and Obsessive-Compulsive Disorders
TABLE 1 | Lifetime Prevalence of OCD by sex and age.
N
(Subtotal)
Prevalence
(%)
χ
2
1df
P OR CI 95%
<25 Men 2 (133) 1.5 –
25–44 8 (381) 2.1 0.01◦ 0.952 0.71 0.10–3.68
45–64 5 (312) 1.6 0.01◦ 0.999 0.93 0.12–5.49
>64 3 (188)◦ 1.6 0.01◦ 0.999 1.01 0.25–4.31
Total men*
[43.4%]
18 (1014) 1.8
<25 Women 7 (137) 5.1 —
25–44 7 (437) 1.6 5.71 0.017 3.41 1.01–
11.01
45–64 9 (429) 2.1 4.99 0.046 2.63 1.00–7.13
>64 3 (250) 1.2 5.60 0.018 4.55 1.01–22.6
Total women*
[56.6%]
26 (1253) 2.0 0.209 0.647 1.15 0.61–2.19
Total (men +
women)
44 (2267) 1.9
*Female vs. Males.
◦With Yates’s correction.
young women aged 18–24 (n = 7 [5.1%]), was higher than in all
other age groups.
Table 2 shows the associations between mood disorders and
OCD. MDD was associated with OCD in 13.6% of all cases of
OCD (OR = 3.69, CI 95% 1.36–9.41). When the set of MDD
was subdivided into those cases with and without subthreshold
episodes of hypomania (MDQ positive and MDQ negative), only
the subgroup of MDD with lifetime subthreshold hypomania,
constituting 4.5% of the whole OCD sample, showed a strong
association with OCD (OR = 18.15, CI 95% 2.45–103.67). In
contrast, the MDD subgroup without subthreshold hypomania,
constituting 9% of the whole OCD sample, showed no association
with OCD (OR = 2.33, CI 95% 0.69–7.01). The BDS group
(as defined above) was also strongly associated with OCD (OR
= 10.5, CI 95% 4.90–12.16). The one participant who was
recognized positive for BD at the ANTAS-SCID also had OCD
(2.8%; OR= 26.6, CI 95% 0.93–384.3).
In terms of the impairment of HR-QoL attributable to OCD
alone, OCD with BDS and OCD without BDS, the results
revealed that OCD alone is a significant factor in compromising
HR-QoL, with mean SF-12 scores of 35.4 ± 6.9 and an
attributable impairment of HR-QoL of 2.9 ± 6.0 in 44 cases as
against 88 controls.We isolated the 12 cases of OCDwith BDS (of
these 12 cases, one also had a diagnosis of BD, 6 had a diagnosis
of Panic Disorder, 2 of MDD [1 of which had comorbid Panic
Disorder], 1 of Post Traumatic Stress Disorder). These cases were
found to have a significantly higher level of impairment of HR-
QoL than the other OCD cases, even though the latter group
included those with MDD screening negative on the MDQ. The
mean SF-12 scores were 33.6 ± 6.7 in those with OCD and BDS,
and it 36.1± 7.1 in those with OCDwithout comorbid BDS, with
an attributable impairment of HR-QoL of, respectively, 6.1± 5.9
(12 cases vs. 48 controls) and 2.1 ± 7.4 (32 cases vs. 64 controls):
F[1;110;111] = 9.49; P < 0.003.
DISCUSSION
The study, which was based on semi-structured clinical
interviews administered by physicians with experience in mental
health, found lower prevalence rates of OCD than the recent
WHO epidemiological survey (8). Our results were closer to
other studies conducted since the 1980s, including those relying
on lay interviewers and structured interviews (3, 5, 27–31),
although caution is needed when comparing these surveys on
account of methodological differences.
Our study showed a higher frequency among younger age
groups, which suggests a youthful onset or a cohort effect (8).
The frequency of the association between Bipolar Disorder
and OCD in our sample (2.8%) is lower than the frequency found
in previous epidemiological studies (10, 11) but in the range
[2–3%] reported in the aforementioned clinical studies (11, 12),
and in studies looking for comorbidity with BD in patients with
OCD (32); this is probably due to methodological differences.
The diagnosis of BD (and OCD) in our study was detected with
a semi-structured interview conducted by clinicians, as opposed
to the community surveys in which the diagnoses are made by
structured interviews conducted by lay interviewers. It is known
that the frequencies of psychiatric disorders identified with the
SCID interview are tendentially low (14). Studies form the same
data-base of the present found lower frequencies of both MDD
(18) and BD (33) compared to other studies conducted by means
of structured interviews.
The notable finding of the present study is the close
association between OCD and BDS including DSM-IV Bipolar
Disorder, DSM-IV Major Depressive Disorder showing
hypomanic subthreshold episodes, and people showing
hypomanic subthreshold episodes without a mood diagnosis.
The association of OCD with the BDS is well-documented in
clinical settings (12, 34).
Our study also found that in a random sample of the
general population the comorbidity between OCD and BDS is
associated with a seriously impaired HR-QoL. That impairment
is considerably less marked in people with OCD who did not
display bipolar spectrum symptoms. The impairment of HR-
QoL attributable to the comorbidity of OCD with the BDS
is substantial, and the measurable burden is equal or very
similar to that of other psychiatric (MDD, Panic Disorder, Eating
Disorders) conditions, as measured in case-control studies that
used the same methodology applied in the present study (35–
38). It should be noted that some of the cases included in the
BDS subgroup also were comorbid with other disorders, such
as Panic Disorder, and this might have influenced the extent of
the impairment of HR-QoL attributable to the comorbidity of
OCD. However, BD is highly comorbid with anxiety disorders
such as Panic Disorder (39), and therefore it might be difficult
to disentangle the impact of the associated hypomania and of
comorbid anxiety disorders when investigating samples that are
distinguished on the basis of their comorbidity with BD.
This finding is consistent with the clinical observation that
cases of OCD in association with BD (including subthreshold
manifestations) are the most severe and have a worse course
(40, 41). The prospective epidemiological Zurich Study, which
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TABLE 2 | Comorbidity between Obsessive Compulsive Disorders and Major Depressive Disorders (MDD) with further subdivision between MDD screening positive on
the MDQ and MDD screening negative on the MDQ; Bipolar Disorders and Bipolar Spectrum Disorders (including BD, MDD positives on the MDQ, and positives on the
MDQ without a diagnosis of BP or MDD).
N Comorbidity with OCD (%) χ2 p OR CI 95%
Major Depressive Disorder 6 (44) 13.6 9.58 0.002 3.69 1.36–9.41
Major Depressive Disorder positives on MDQ 2 (44) 4.5 12.37* <0.0001 18.15 2.45–103.67
Major Depressive Disorder negatives on MDQ 4 (44) 9.0 2.67 0.102 2.33 0.69–7.01
Bipolar Disorder 1 (44) 2.8 3.55* 0.059 26.6 0.93–384.3
All positives on MDQ = Bipolar Spectrum (Bipolar
Disorder + MDD/MDQ+ + MDQ+ without diagnosis of
MDD or BP)
12 (44) 27.2 65.49* <0.0001 10.5 4.90–12.16
*With Yates’s Correction.
MDQ+ = screening positive on the MDQ.
analyzed two groups of probands from age 20 to 40, one having
OCDwith BD, the other without, showed more chronic episodes,
residual symptoms and previous recurrence of depressive
episodes in the comorbid group. In the comorbid group higher
rates of anxiety disorders, impulse control disorders, eating
disorders, and tic disorders were also found (17). The follow-up
analysis to age 50 also confirmed that the co-occurrence of OCD
and bipolar spectrum (including subthreshold bipolar disorder)
was associated with significantly higher levels of treatment-
seeking, impairment, distress, suicidality, and an increased risk
of alcohol abuse/dependence compared with “pure” OCD (2),
although this is not an universal finding (42). A poorer quality
of life was also indicated as a specific feature of bipolar-
OCD comorbidity (41). In agreement with these results, our
study found that the association of OCD with BDS produced
more substantial impairment than those with comorbid MDD
but without bipolar spectrum symptomatology. Given that a
diagnosis ofMDD is known to be amajor determinant of reduced
HR-QoL when comorbid with other psychiatric conditions (18),
this finding emphasizes the damaging effect of BDS on HRQoL,
with or without diagnosis of a mood disorder, when combined
with OCD.
Criticism has been leveled against the use of screening
questionnaires to detect cases of BD. It is argued that only
a small percentage of “positives” on such screening tools
would be recognized as having BD if they were to undergo
a structured interview using DSM as the diagnostic gold
standard (23, 43, 44). However, our research has provided
clear evidence that the wide spectrum of “false positives” that
emerge when screening for BDS (i.e., being positive at screening
but below the diagnostic threshold according to the gold
standard international descriptive criteria) show demographic
characteristics, a comorbidity profile, a type of social impairment,
drug and health care use, and have brain imaging profiles that
indicate that they belong to clearly defined subthreshold bipolar
spectrum group (14, 18). It is also interesting to note that in
the previously mentioned clinical studies on OCD, many of
the characteristics identified as defining OCD comorbid with
bipolar subthreshold, namely anxiety disorders, substance abuse,
personality disorders, and the risk of suicide, are also to be found
among the so-called “false positives” identified by screening tools
such as MDQ, i.e., people positive at the screening but who did
not fulfill the DSM-IV criteria for BD (14).
The results suggest that screening people with OCD for
symptoms of hypomania is crucial, as the comorbidity represents
an important marker of severity and risk of impairment. The fact
that longitudinal clinical studies have also found that the presence
of hypomanic symptoms (including subthreshold symptoms)
is a predictor of treatment response (45–47) adds strength to
the argument.
STRENGTHS AND LIMITATIONS
This study has both strengths and limitations. The main
strengths are the use of structured, standardized instruments
for measurement, and the investigation in a reasonably large,
community-based sample randomly drawn from the municipal
records of geographical areas expected to be representative of the
socio-cultural characteristics of the entire national territory.
The most important limitation is that, although the research
is a community survey with a large sample, the focus of this
research was not the main objective of the project. The sample
was built on the basis of the expected frequencies of subthreshold
mania (focus of main objective of the whole project), which was
estimated at 4% (18), while the lifetime prevalence of OCD (focus
on this secondary objective) was found in this study to be <2%.
Thus, the hypotheses that can arise from the reading of these data
have a heuristic and stimulating value rather than a conclusive
one. The results must therefore be confirmed by future studies
with larger samples and specifically focused on this topic.
Another important limitation is that we used ratings on
the MDQ to identify a diagnostic group (“subthreshold bipolar
disorders”) that is hard to pin down and is particularly
controversial. Additional limitations include the lack of details on
some correlates of BDS comorbidity among OCD participants,
which could be of interest on a clinical ground (e.g., OCD
course and severity, symptom dimensions, suicidality, other
comorbidities); lack of statistical power for some analysis due to
the small size of some subsamples; lack of information on some
unexplored comorbidities, such as impulse control disorder or
personality disorders, which could have a differential impact on
HR-QoL in the two study groups.
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CONCLUSIONS
These results from a random sample of the general population
have found a strong association between mood disorders
including bipolar and subthreshold bipolar symptomatology
and the diagnosis of OCD. These findings confirm that cases
of BDS comorbid with OCD are associated with more severe
impairment of quality of life. The identification of symptoms of
hypomania, including subthreshold symptoms, may therefore be
crucial in people with OCD. The results must be confirmed by
future studies.
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